Compliance Note: Consultation Fees

We’re just around the corner from the 2017 AEP. As you prepare your advertisements, please remember that it is against CMS guidelines to charge a beneficiary a consultation fee for a review of their Medicare Advantage or Prescription Drug Plan.

From the 2016 CMS Marketing Guidelines:

120.5—Additional Marketing Fees

42 CFR 422.2274, 423.2274

A Plan/Part D Sponsor may not charge a beneficiary or allow its marketing representative to charge a beneficiary a marketing fee. All costs associated with the marketing of a plan are the responsibility of the Plan/Part D Sponsor.

If you have an advertisement that you are looking to use during the AEP, please send it to compliance@urlinsgroup.com for a review.